Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma (Q33371197)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma |
scientific article |
Statements
1 reference
Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma (English)
1 reference
Bolling C
1 reference
Graefe T
1 reference
Lübbing C
1 reference
Jankevicius F
1 reference
Uktveris S
1 reference
Cesas A
1 reference
Meyer-Moldenhauer WH
1 reference
Starkmann H
1 reference
Weigel M
1 reference
Burk K
1 reference
Hanauske AR
1 reference
1 November 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference